Fluoroquinolone Resistance in Atypical Pneumococci and Oral Streptococci: Evidence of Horizontal Gene Transfer of Fluoroquinolone Resistance Determinants from Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

Atypical strains, presumed to be pneumococcus, with ciprofloxacin MICs of > or =4.0 microg/ml and unique sequence variations within the quinolone resistance-determining regions (QRDRs) of the gyrase and topoisomerase genes in comparison with the Streptococcus pneumoniae R6 strain, were examined. These strains were reidentified using phenotypic methods, including detection of optochin susceptibility, bile solubility, and agglutination by serotype-specific antisera, and genotypic methods, including detection of pneumolysin and autolysin genes by PCR, 16S rRNA sequencing, and multilocus sequence typing (MLST). The analysis based on concatenated sequences of the six MLST loci distinguished the "atypical" strains from pneumococci, and these strains clustered closely with S. mitis. However, all these strains and five of nine strains from the viridans streptococcal group possessed one to three gyrA, gyrB, parC, and parE genes whose QRDR sequences clustered with those of S. pneumoniae, providing evidence of horizontal transfer of the QRDRs of the gyrase and topoisomerase genes from pneumococci into viridans streptococci. These genes also conferred fluoroquinolone resistance to viridans streptococci. In addition, the fluoroquinolone resistance determinants of 32 well-characterized Streptococcus mitis and Streptococcus oralis strains from bacteremic patients were also compared. These strains have unique amino acid substitutions in GyrA and ParC that were distinguishable from those in fluoroquinolone-resistant pneumococci and the "atypical" isolates. Both recombinational events and de novo mutations play an important role in the development of fluoroquinolone resistance.

Knowledge Graph

Similar Paper

Fluoroquinolone Resistance in Atypical Pneumococci and Oral Streptococci: Evidence of Horizontal Gene Transfer of Fluoroquinolone Resistance Determinants from Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2007.0
First Characterization of Fluoroquinolone Resistance in Streptococcus suis
Antimicrobial Agents and Chemotherapy 2007.0
Interspecies Recombination Occurs Frequently in Quinolone Resistance-Determining Regions of Clinical Isolates of Streptococcus pyogenes
Antimicrobial Agents and Chemotherapy 2008.0
Fitness of Streptococcus pneumoniae Fluoroquinolone-Resistant Strains with Topoisomerase IV Recombinant Genes
Antimicrobial Agents and Chemotherapy 2008.0
Real-Time PCR Detection of gyrA and parC Mutations in Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2008.0
Prevalence, Characteristics, and Molecular Epidemiology of Macrolide and Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae at Five Tertiary-Care Hospitals in Korea
Antimicrobial Agents and Chemotherapy 2007.0
Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates
Antimicrobial Agents and Chemotherapy 2009.0
Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae
Antimicrobial Agents and Chemotherapy 2007.0
Emergence of Fluoroquinolone Resistance in Group B Streptococcal Isolates in Taiwan
Antimicrobial Agents and Chemotherapy 2008.0
Mechanisms of Resistance in Nontyphoidal Salmonella enterica Strains Exhibiting a Nonclassical Quinolone Resistance Phenotype
Antimicrobial Agents and Chemotherapy 2009.0